Natalia Vodianova Invests in Swiss Beauty and Longevity Brand NIANCE
ZURICH, June 28, 2024 /PRNewswire/ -- Swiss Health & bioBeauty AG, owner of the prestigious beauty and longevity brand NIANCE, announces that internationally renowned supermodel, philanthropist, and investor Natalia Vodianova has become one of the key shareholders of NIANCE. This strategic partnership marks a significant milestone in the brand's journey towards global prominence. About NIANCE NIANCE is a...
GC Biopharma Ships First Doses of World’s First Recombinant Anthrax Vaccine, ‘BARYTHRAX inj.’
- First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC Biopharma's facility YONGIN, South Korea, Dec. 8, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading global biopharmaceutical company, today announced the first shipment of BARYTHRAX inj., the world's first recombinant anthrax vaccine....
The 20th International Congress on Luobing Theory Held in Shijiazhuang
SHIJIAZHUANG, China, Feb. 28, 2024 /PRNewswire/ -- On February 24, the 20th International Congress on Luobing Theory was held in Shijiazhuang, which consisted of 1 main forum and 12 sub-forums. Approximately 20 academicians from both Chinese Academy of Sciences and Chinese Academy of Engineering, including Zhang Boli, Fan Daiming, Liu Depei, Zhang Yun and Wu Yiling (Founder of Yiling...
Hanmi Unveils Novel Obesity Drug ‘HM17321’ : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss
Fat Loss Augmentation + Lean Mass Increase Hanmi Presents Three Breakthrough Findings on Novel Obesity Drugs at 2024 ObesityWeekHigh Quality Obesity Management by Targeting the CRF2 Receptor: Enhanced Fat Loss with Lean Mass IncreaseImproved Weight Loss and Muscle Preservation with HM15275 Combination Therapy SEOUL, South Korea, Nov. 6, 2024 /PRNewswire/ -- Hanmi...
Meihua International Medical Technologies Co., Ltd.’s Subsidiary Completes Purchase of Land Use Right of Nearly 50,000 Square Meters in Hainan Free Trade Port Boao Hope City for the Construction...
YANGZHOU, China, May 1, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced the Company, via its subsidiary Hainan Guoxie Technology Group Co., Ltd. ("Hainan Guoxie"), has completed the purchase of...
Duality Biologics Announces Expansion of Adcendo ApS Collaboration Through Option Exercise of Strategic License Agreement
Adcendo ApS exercises its option to utilize Duality Biologics' platform to further enhance its first-in-class ADC pipeline PRINCETON, N.J., SHANGHAI and SUZHOU, China, Nov. 26, 2024 /PRNewswire/ -- Duality Biologics ("Duality"), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate therapeutics today announced the expansion of...
Biostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis
SAN FRANCISCO, July 5, 2024 /PRNewswire/ -- Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Biostar), which is a synthetic biology-driven biopharma company focusing on the development and commercialization of innovative oncology drugs, announced today that their core pipeline product Utidelone Injection (UTD1) had been granted to conduct a phase 2 study (BG01-2402) for...
Jacob’s Encourages Malaysians to Take the First Step Towards a Healthier Lifestyle with ‘Langkah Kebaikan 65’ Movement
KUALA LUMPUR, Malaysia, Aug. 22, 2022 /PRNewswire/ -- To celebrate and in commemoration of Malaysia's 65th Independence Day, Jacob's Malaysia has launched its #LangkahKebaikan65 campaign which aims to collect 10 million steps and encourage Malaysians to adopt a healthier lifestyle as well as be more active. Jacob's Malaysia is a heritage brand that believes in and encourages people to...
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease
TAMPA, Fla., May 1, 2023 /PRNewswire/ -- The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc's novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary arteries. Concept Medical has received its third US FDA IDE approval for the...
AffaMed Therapeutics Announces First Patient Treated in Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery
SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmologic, neurological and psychiatric disorders, today announced that the first patient has been treated in the Phase 3 registrational study in China to investigate the efficacy and safety...
